• Dabigatran in Anticoagulation Assays: Protocols and Innovati

  2026-04-30

  Dabigatran (Pradaxa), a gold-standard direct thrombin inhibitor, empowers high-precision coagulation function tests and advanced anticoagulation research. This article translates recent metabolomics-driven insights and validated workflows into actionable steps for optimizing thrombin inhibition assays and troubleshooting common laboratory challenges.

• Sulfo-NHS-SS-Biotin: Precision Reversible Biotinylation for

  2026-04-29

  The Sulfo-NHS-SS-Biotin Kit enables high-specificity, reversible protein and antibody biotinylation for mapping and purifying cell surface interactomes. Its water-soluble, disulfide-cleavable design allows for dynamic profiling and efficient affinity workflows, addressing key challenges in advanced proteomics and cell surface biology.

• Sulfo-NHS-SS-Biotin: Dynamic Reversible Labeling for Cell Su

  2026-04-29

  Unlock the potential of reversible biotinylation with Sulfo-NHS-SS-Biotin for high-fidelity cell surface proteome mapping. This kit enables selective, gentle purification and interactome analysis, supporting cutting-edge workflows in extracellular protein and glycoRNA domain discovery.

• Sulfo-NHS-SS-Biotin: Precision Protein Labeling for Affinity

  2026-04-28

  Sulfo-NHS-SS-Biotin enables highly selective, reversible protein labeling for advanced affinity purification and cell surface proteomics. Its cleavable disulfide linker and water solubility streamline workflows and empower dynamic interactome studies.

• Ribociclib Succinate: Strategic CDK Inhibition in Translatio

  2026-04-28

  This thought-leadership article explores the mechanistic, experimental, and translational dimensions of LEE011 succinate (Ribociclib succinate) as a selective CDK4/6 inhibitor. Integrating evidence-based protocols, competitive analysis, and clinical context, it delivers actionable guidance for researchers striving to optimize cell proliferation assays and advance precision oncology. The article positions APExBIO’s Ribociclib succinate at the forefront of translational innovation, bridging mechanistic insight with workflow-centric strategy.

• Lignans from Rosemary Roots: Novel Anti-Inflammatory Insight

  2026-04-27

  This study systematically identifies and characterizes eight lignans and four phenylpropanoids, including three novel compounds, from Rosmarinus officinalis roots. The research demonstrates potent, dose-dependent anti-inflammatory activity of several isolated lignans in an LPS-induced RAW264.7 macrophage model, underscoring the underexplored pharmacological value of rosemary root constituents.

• Necrosulfonamide in Necroptosis Assays: Protocols & Insights

  2026-04-27

  Necrosulfonamide (NSA) enables precise dissection of necroptotic cell death via selective MLKL inhibition, advancing both cancer and cardiovascular research. This guide translates breakthrough findings and published workflows into actionable protocols, troubleshooting advice, and strategic considerations for optimizing necroptosis assays.

• U 46619: Precision Tool for Platelet Aggregation and Vascula

  2026-04-26

  U 46619 (11,9 epoxymethano-prostaglandin H2) stands out as a highly selective agonist for dissecting platelet and vascular signaling, enabling reproducible, high-sensitivity modeling of cardiovascular dynamics. This article translates advanced research and field-tested protocols into actionable strategies for applied platelet aggregation, serotonin release, and renal vasoconstriction studies.

• PEDV Infection Disrupts NHE3 Activity, Driving Diarrhea in P

  2026-04-25

  This study demonstrates that porcine epidemic diarrhea virus (PEDV) infection in neonatal piglets specifically reduces the activity and membrane localization of the Na+/H+ exchanger NHE3, a key regulator of intestinal sodium absorption. These findings clarify the molecular basis for PEDV-induced diarrhea and highlight the importance of NHE3 in gut epithelial physiology.

• Refining In Vitro Drug Response Metrics in Cancer Research

  2026-04-24

  Schwartz (2022) introduces a comparative framework for in vitro drug response evaluation, distinguishing between growth arrest and cell death in anti-cancer drug assays. This approach enhances the interpretation of kinase inhibitor effects, supporting more precise modeling of therapeutic impact in chronic myeloid leukemia and related cancer research.

• Sulfo-NHS-SS-Biotin: Protocol-Driven Protein Labeling Guide

  2026-04-24

  Sulfo-NHS-SS-Biotin is designed for efficient, water-soluble biotinylation of primary amines, particularly for cell surface protein labeling and affinity purification workflows. Researchers should use this reagent where reversible biotin conjugation and high aqueous solubility are required, but avoid scenarios needing intracellular labeling or long-term solution stability.

• AMPK Restricts Autophagy by Inhibiting ULK1 During Energy St

  2026-04-23

  This study redefines the role of AMPK in cellular energy stress, demonstrating that AMPK inhibits, rather than activates, ULK1-mediated autophagy during glucose deprivation. These findings reshape our understanding of energy sensing and autophagy regulation, with implications for research on cell survival mechanisms under nutrient limitation.

• Pexidartinib (PLX3397): Technical Guidance for CSF1R Inhibit

  2026-04-23

  Pexidartinib (PLX3397) is a selective ATP-competitive CSF1R inhibitor designed for research applications involving macrophage modulation and tumor microenvironment studies. It is best suited for workflows investigating CSF1R-mediated signaling inhibition and apoptosis induction in cancer models. Its use is not recommended in diagnostic or clinical settings, nor for long-term solution storage.

• Lysoptosis: Conserved Cell Death Pathway Defined by Serpin M

  2026-04-22

  Luke et al. (2022) identify lysoptosis as a distinct, evolutionarily conserved lysosome-dependent cell death (LDCD) pathway, characterized by lysosomal membrane permeabilization and cathepsin release, and regulated by intracellular serpins. This work clarifies the mechanistic role of cysteine proteases in cell death and has implications for experimental modulation of apoptosis and related pathways.

• CX-5461: Applied Workflows for RNA Polymerase I Inhibition i

  2026-04-22

  CX-5461, a potent RNA polymerase I inhibitor, enables precise interrogation of ribosome biogenesis and solid tumor growth inhibition in translational cancer models. This guide distills recent high-impact findings and offers pragmatic protocols and troubleshooting strategies for maximizing experimental reliability and translational relevance.

16728 records 1/1116 page Next 12345 下5页 Last page